Imhotex Limited is a company headquartered in the United Kingdom.
Imhotex Limited is a virtual drug development company focused on developing innovative pharmaceuticals, including a product candidate for Crohn’s Disease, by leveraging specialist service providers.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.